243 related articles for article (PubMed ID: 33251890)
1. Inter-observer reliability in ultrasound measurement of benign thyroid nodules in the follow-up of radiofrequency ablation: a retrospective study.
Yan L; Luo Y; Song Q; Li N; Xiao J; Zhang Y; Zhu Y
Int J Hyperthermia; 2020 Nov; 37(1):1336-1344. PubMed ID: 33251890
[TBL] [Abstract][Full Text] [Related]
2. Non-enhanced ultrasound is not a satisfactory modality for measuring necrotic ablated volume after radiofrequency ablation of benign thyroid nodules: a comparison with contrast-enhanced ultrasound.
Yan L; Luo Y; Xiao J; Lin L
Eur Radiol; 2021 May; 31(5):3226-3236. PubMed ID: 33128600
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound is a reliable and reproducible assessment of necrotic ablated volume after radiofrequency ablation for benign thyroid nodules: a retrospective study.
Yan L; Li X; Xiao J; Li Y; Zhu Y; He H; Luo Y
Int J Hyperthermia; 2022; 39(1):40-47. PubMed ID: 34936850
[TBL] [Abstract][Full Text] [Related]
4. Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.
Bisceglia A; Rossetto R; Garberoglio S; Franzin A; Cerato A; Maletta F; Papotti MG; Ghigo E; Pagano L; Maccario M; Garberoglio R
Front Endocrinol (Lausanne); 2021; 12():638880. PubMed ID: 34079521
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.
Li L; Qiu X
Thyroid; 2022 May; 32(5):525-535. PubMed ID: 34915754
[No Abstract] [Full Text] [Related]
6. Twelve-Month Volume Reduction Ratio Predicts Regrowth and Time to Regrowth in Thyroid Nodules Submitted to Laser Ablation: A 5-Year Follow-Up Retrospective Study.
Negro R; Greco G; Deandrea M; Rucco M; Trimboli P
Korean J Radiol; 2020 Jun; 21(6):764-772. PubMed ID: 32410415
[TBL] [Abstract][Full Text] [Related]
7. Differences in the ultrasonographic appearance of thyroid nodules after radiofrequency ablation.
Wu MH; Chen KY; Chen A; Chen CN
Clin Endocrinol (Oxf); 2021 Sep; 95(3):489-497. PubMed ID: 33938024
[TBL] [Abstract][Full Text] [Related]
8. Residual, regrowth, and new growth of radiofrequency ablation for benign thyroid nodules of different volumes: two-year follow-up results.
Chen MH; Lin WC; Luo SD; Chiang PL; Chen YS; Chen WC; Lin AN; Wang CK; Baek JH; Chen HL
Int J Hyperthermia; 2022; 39(1):1172-1178. PubMed ID: 36096486
[TBL] [Abstract][Full Text] [Related]
9. Effect of ultrasound parameters of benign thyroid nodules on radiofrequency ablation efficacy.
Motaghed Z; Chegeni H; Mosadeghkhah A; Azimi Aval M; Gerami R; Ebrahiminik H
BMC Med Imaging; 2023 Jun; 23(1):85. PubMed ID: 37337132
[TBL] [Abstract][Full Text] [Related]
10. Determining an energy threshold for optimal volume reduction of benign thyroid nodules treated by radiofrequency ablation.
Deandrea M; Trimboli P; Mormile A; Cont AT; Milan L; Buffet C; Giovanella L; Limone PP; Poirée S; Leenhardt L; Russ G
Eur Radiol; 2021 Jul; 31(7):5189-5197. PubMed ID: 33409792
[TBL] [Abstract][Full Text] [Related]
11. Residual vital ratio: predicting regrowth after radiofrequency ablation for benign thyroid nodules.
Yan L; Luo Y; Xie F; Zhang M; Xiao J
Int J Hyperthermia; 2020; 37(1):1139-1148. PubMed ID: 32996790
[TBL] [Abstract][Full Text] [Related]
12. CT-based quantitative evaluation of the efficacy after radiofrequency ablation in patients with benign thyroid nodules.
Choi Y; Jung SL; Jang J; Shin NY; Ahn KJ; Kim BS
Int J Hyperthermia; 2020; 37(1):742-748. PubMed ID: 33480816
[TBL] [Abstract][Full Text] [Related]
13. Learning curve for radiofrequency ablation of benign thyroid nodules.
Russ G; Ben Hamou A; Poirée S; Ghander C; Ménégaux F; Leenhardt L; Buffet C
Int J Hyperthermia; 2021; 38(1):55-64. PubMed ID: 33491515
[No Abstract] [Full Text] [Related]
14. Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study.
Yan L; Luo Y; Zhang M; Xiao J
Int J Hyperthermia; 2020; 37(1):777-785. PubMed ID: 32619366
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of radiofrequency ablation for benign thyroid nodules in patients with previous thyroid lobectomy.
Yan L; Zhang M; Xie F; Ma J; Xiao J; Luo Y
BMC Med Imaging; 2021 Mar; 21(1):47. PubMed ID: 33706713
[TBL] [Abstract][Full Text] [Related]
16. Initial Ablation Ratio Predicts Volume Reduction and Retreatment After 5 Years From Radiofrequency Ablation of Benign Thyroid Nodules.
Bernardi S; Cavallaro M; Colombin G; Giudici F; Zuolo G; Zdjelar A; Dobrinja C; De Manzini N; Zanconati F; Cova MA; Stacul F; Fabris B
Front Endocrinol (Lausanne); 2020; 11():582550. PubMed ID: 33597921
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of single-session radiofrequency ablation for benign thyroid nodules of different sizes: a retrospective study.
Lin WC; Kan NN; Chen HL; Luo SD; Tung YC; Chen WC; Chou CK; Chi SY; Chen MH; Su YY; Cheng KL; Baek JH
Int J Hyperthermia; 2020; 37(1):1082-1089. PubMed ID: 32964743
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients.
Jeong WK; Baek JH; Rhim H; Kim YS; Kwak MS; Jeong HJ; Lee D
Eur Radiol; 2008 Jun; 18(6):1244-50. PubMed ID: 18286289
[TBL] [Abstract][Full Text] [Related]
19. Computer-Analyzed Ultrasound Predictors of the Treatment Efficacy of Radiofrequency Ablation for Benign Thyroid Nodules.
Kuo CY; Wu MH; Ko WC; Cheng SP
World J Surg; 2022 Jan; 46(1):112-120. PubMed ID: 34608544
[TBL] [Abstract][Full Text] [Related]
20. Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules.
Dong Y; Zhan W; Zhou J; Li N; Liu Z; Xia S; Ni X; Liu J; Zhang J; Xu S; Yang Z; Hua Q
Eur Radiol; 2024 Mar; 34(3):1597-1604. PubMed ID: 37665388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
